| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
110.27(B) |
| Last
Volume: |
6,919,020 |
Avg
Vol: |
8,403,954 |
| 52
Week Range: |
$48.64 - $76.12 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
319,019 |
515,317 |
1,014,661 |
2,126,174 |
| Total Sell Value |
$23,643,548 |
$35,409,189 |
$61,747,133 |
$111,248,213 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
15 |
27 |
45 |
80 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Butcher Arthur C |
EVP&Pres, Asia Pacific |
• • – |
2022-02-28 |
4 |
D |
$44.17 |
$28,269 |
D/D |
(640) |
35,136 |
|
- |
|
| Butcher Arthur C |
EVP&Pres, Asia Pacific |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,528 |
35,776 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2022-02-28 |
4 |
D |
$44.17 |
$24,912 |
D/D |
(564) |
177,258 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,630 |
177,822 |
|
- |
|
| Meredith Ian T |
EVP Global Chief Med Officer |
• • – |
2022-02-28 |
4 |
D |
$44.17 |
$13,251 |
D/D |
(300) |
34,670 |
|
- |
|
| Meredith Ian T |
EVP Global Chief Med Officer |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,019 |
34,970 |
|
- |
|
| Olson Scott |
SVP & Pres, CRM, Diagnostics |
• • – |
2022-02-28 |
4 |
D |
$44.17 |
$33,834 |
D/D |
(766) |
15,218 |
|
- |
|
| Olson Scott |
SVP & Pres, CRM, Diagnostics |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,426 |
15,984 |
|
- |
|
| Monson Jonathan |
VP, Global Controller and CAO |
• • – |
2022-02-28 |
4 |
D |
$44.17 |
$10,512 |
D/D |
(238) |
31,319 |
|
- |
|
| Monson Jonathan |
VP, Global Controller and CAO |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
815 |
31,557 |
|
- |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2022-02-28 |
4 |
D |
$44.17 |
$87,810 |
D/D |
(1,988) |
275,319 |
|
- |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,481 |
277,307 |
|
- |
|
| Eddy Jodi Euerle |
SVP, Chief Info & Digital Off. |
• • – |
2022-02-28 |
4 |
D |
$44.17 |
$18,507 |
D/D |
(419) |
26,042 |
|
- |
|
| Eddy Jodi Euerle |
SVP, Chief Info & Digital Off. |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,426 |
26,461 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2022-02-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,300 |
161,262 |
|
- |
|
| Pierce David A |
EVP Pres MedSurg |
• • – |
2022-02-23 |
4 |
AS |
$43.28 |
$76,216 |
D/D |
(1,761) |
0 |
|
-14% |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2022-02-22 |
4 |
AS |
$42.75 |
$2,273,621 |
D/D |
(53,182) |
272,826 |
|
-12% |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2022-02-22 |
4 |
OE |
$7.39 |
$771,751 |
D/D |
53,182 |
326,008 |
|
- |
|
| Pierce David A |
EVP Pres MedSurg |
• • – |
2022-02-22 |
4 |
AS |
$42.55 |
$80,164 |
D/D |
(1,884) |
1,761 |
|
-12% |
|
| Brown Vance R |
SVP, GC and Corp. Secretary |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$9,787 |
D/D |
(230) |
32,036 |
|
- |
|
| Brown Vance R |
SVP, GC and Corp. Secretary |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
779 |
32,266 |
|
- |
|
| Sorenson John Bradley |
SVP, Global Supply Chain |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$14,212 |
D/D |
(334) |
36,199 |
|
- |
|
| Sorenson John Bradley |
SVP, Global Supply Chain |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,090 |
36,533 |
|
- |
|
| Olson Scott |
SVP & Pres, CRM, Diagnostics |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$25,785 |
D/D |
(606) |
14,558 |
|
- |
|
| Olson Scott |
SVP & Pres, CRM, Diagnostics |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,090 |
15,164 |
|
- |
|
4540 Records found
|
|
Page 19 of 182 |
|
|
0.99 (1.3%) 
